Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer

Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer which does not respond to hormone therapy. Research of NEPC has been hampered by a lack of clinically relevant in vivo models. Recently, we developed a first-in-field patient tissue-derived xenograft model of complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dong, Dong, Xin, Wang, Kendric, Wyatt, Alexander W., Crea, Francesco, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Bell, Robert H., Haegert, Anne, Brahmbhatt, Sonal, Hurtado-Coll, Antonio, Gout, Peter W., Fazli, Ladan, Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359333/
https://www.ncbi.nlm.nih.gov/pubmed/25544761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359333/
https://www.ncbi.nlm.nih.gov/pubmed/25544761

Ejemplares similares